PharmaShots | Incisive News in 3 Shots

Subscribe Now

hereditary angioedema (HAE)

Biocryst's Orladeyo (berotralstat) Receives the US FDA's Approval to Prevent Attacks of Hereditary Angioedema (HAE)

Biocryst's Orladeyo (berotralstat) Receives the US FDA's Approval to Prevent Attacks of Hereditary Angioedema (HAE)

December 15, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us